Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19
Article 2021 en
Authors
PJ
Perrine Janiaud
CA
Cathrine Axfors
AS
Andreas M. Schmitt
Abstract
1 min read
Treatment with convalescent plasma compared with placebo or standard of care was not significantly associated with a decrease in all-cause mortality or with any benefit for other clinical outcomes. The certainty of the evidence was low to moderate for all-cause mortality and low for other outcomes.
Thomas Thomopoulos, Anthi Bouchla, Anastasia Antoniadou, Evangelos Terpos, Maria Politou, Konstantinos Stamoulis, Eleni Koromboki, Sotirios G. Papageorgiou, Αnastasia Kotanidou, Ioannis Kalomenidis, Edison Jahaj, Sotiria Grigoropoulou, Maria Pagoni, Elisavet Grouzi, Garyphallia Poulakou, Ioannis P. Trontzas, Stavroula Labropoulou, Alexios‐Fotios A. Mentis, A Bamias, Sotirios Tsiodras, Meletios A Dimopoulos, Vasilliki Pappa
Muthiah Vaduganathan, Baljash Cheema, Erin R. Cleveland, K. Nathan Sankar, Haris Subačius, Gregg C. Fonarow, Scott D. Solomon, Eldrin F. Lewis, Stephen J. Greene, Aldo Maggioni, Michael Böhm, Faı̈ez Zannad, Javed Butler, Mihai Gheorghiade
Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, Janneke van ’t Hooft, Sherief Abd‐Elsalam, Ehab Fawzy Abdo, Benjamin S. Abella, Javed Akram, Ravi K. Amaravadi, Derek Angus, Yaseen M. Arabi, Shehnoor Azhar, Lindsey R. Baden, Arthur W. Baker, Leïla Belkhir, Thomas Benfield, Marvin A. H. Berrevoets, Cheng‐Pin Chen, Tsung‐Chia Chen, Shu‐Hsing Cheng, Chien‐Yu Cheng, Wei‐Sheng Chung, Yehuda Z. Cohen,
Discussion(0)
No comments yet. Be the first to comment.